1. When Is Biologic Therapy Appropriate for HS?

2. This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were presented in abstract form.

3. Introduction to HS

4. General Treatment Options for HS According to Disease Severity

5. Effectiveness of Current Therapies Importance of Accurate Staging

6. Assessing Signs and Symptoms

7. Candidates for Biologic Therapy

8. TNF Inhibitors Adalimumab

9. TNF Inhibitors Adalimumab (cont)

10. TNF Inhibitors Infliximab

11. TNF Inhibitors in Practice

12. Other Biologics

13. Shared Decision Making When to Use a Biologic

14. Shared Decision Making When to Use a Biologic (cont)

15. Shared Decision Making Managing Patient Expectations

16. Shared Decision Making Lifestyle Modifications

17. When to Halt Therapy?

18. Concluding Remarks

19. Abbreviations